###begin article-title 0
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
The SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 342 348 <span type="species:ncbi:10090">murine</span>
Pseudoautosomal regions (PAR1 and PAR2) in eutherians retain homologous regions between the X and Y chromosomes that play a critical role in the obligatory X-Y crossover during male meiosis. Genes that reside in the PAR1 are exceptional in that they are rich in repetitive sequences and undergo a very high rate of recombination. Remarkably, murine PAR1 homologs have translocated to various autosomes, reflecting the complex recombination history during the evolution of the mammalian X chromosome.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
We now report that the SNF2-type chromatin remodeling protein ATRX controls the expression of eutherian ancestral PAR1 genes that have translocated to autosomes in the mouse. In addition, we have identified two potentially novel mouse PAR1 orthologs.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We propose that the ancestral PAR1 genes share a common epigenetic environment that allows ATRX to control their expression.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The sex chromosomes in modern placental mammals (eutherians) are highly dimorphic but initially evolved from a homologous pair of autosomes [1]. Over millions of years of mammalian evolution, the sex chromosomes have lost most of their homology due to chromosome Y attrition [2]. The remaining homology between the sex chromosomes exists in the pseudoautosomal regions (PARs), located at the ends of the X and Y chromosomes [3] and was generated when genetic material from the tips of autosomes translocated to the ancient sex chromosomes [4]. Gene dosage between XX females and XY males is usually achieved by the silencing of one X chromosome in every female cell, a process known as X chromosome inactivation (XCI) [5]. Because both males and females have two copies of all PAR genes there is no requirement for dosage compensation and these genes therefore escape this inactivation process [6].
###end p 9
###begin p 10
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 811 812 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1066 1072 1066 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Csf2ra</italic>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd99</italic>
###xml 1223 1229 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy</italic>
###xml 1260 1261 1260 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1328 1333 1328 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL</italic>
###xml 1399 1403 1399 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE</italic>
###xml 1405 1409 1405 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD</italic>
###xml 1411 1415 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSF</italic>
###xml 1421 1425 1421 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSH</italic>
###xml 1506 1507 1506 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 67 71 <span type="species:ncbi:9615">dogs</span>
###xml 76 80 <span type="species:ncbi:9685">cats</span>
###xml 100 106 <span type="species:ncbi:9913">cattle</span>
###xml 108 113 <span type="species:ncbi:9940">sheep</span>
###xml 115 119 <span type="species:ncbi:9823">pigs</span>
###xml 175 181 <span type="species:ncbi:9606">humans</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 515 521 <span type="species:ncbi:9606">humans</span>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
###xml 859 864 <span type="species:ncbi:9606">human</span>
###xml 931 936 <span type="species:ncbi:10090">mouse</span>
###xml 942 947 <span type="species:ncbi:9606">human</span>
###xml 1088 1093 <span type="species:ncbi:10090">mouse</span>
###xml 1267 1272 <span type="species:ncbi:9606">Human</span>
###xml 1492 1497 <span type="species:ncbi:10090">mouse</span>
###xml 1651 1656 <span type="species:ncbi:10090">mouse</span>
Comparison of human PARs with those of other primates, carnivores (dogs and cats) and artiodactyls (cattle, sheep, pigs; representing the common evolutionary ancestor between humans and mice) has revealed that gene content is mostly conserved in eutherians, including the existence of PARs at both ends of the X and Y chromosomes [4]. However, rodents are strikingly different in that they have a single, dissimilar and considerably shorter PAR region [7]. Fewer than half of the 24 PAR1 genes identified so far in humans have also been found in the mouse genome, and all have diverged considerably [7]. This divergence is largely due to the increased recombination rates in the PARs during male meiosis [8]. In addition, the PARs comprise a unique chromosomal environment that is rich in repetitive sequences [9,10]. For these reasons, the identification of human PAR genes and orthologs has been difficult. Interestingly, in the mouse, all human PAR1 orthologs identified to date are located on autosomes. For example, colony stimulating factor 2 receptor, alpha (Csf2ra) is located on mouse chromosome 19 [11] and CD99 antigen (Cd99) and Dehydrogenase/reductase short-chain dehydrogenase/reductase family, X chromosome (Dhrsxy) are located on chromosome 4 [9,12]. Human orthologs of acetylserotonin O-methyltransferase-like (ASMTL) and several members of the arylsulfatase (ARS) family of genes (ARSE, ARSD, ARSF, and ARSH) located just outside the PAR1, have not yet been reported in the mouse (Figure 1). Due to their location in the PAR region of evolutionary ancestors, and their current autosomal location, we will refer to these genes in the mouse as "ancestral PAR genes".
###end p 10
###begin p 11
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evolution of PAR genes in humans and mice</bold>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CSF2RA </italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL </italic>
###xml 430 437 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHRSXY </italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD99 </italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD </italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 26 32 <span type="species:ncbi:9606">humans</span>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 191 197 <span type="species:ncbi:9606">humans</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 504 509 <span type="species:ncbi:9606">Human</span>
Evolution of PAR genes in humans and mice. PAR genes that are downregulated in the ATRX-null mouse forebrain are clustered together within the PAR1 region of common evolutionary ancestors of humans and mice but have translocated to autosomes in the mouse. Vertical lines and arrows represent individual genes. The position of the first nucleotide of each gene is as follows: SHOX (505,079), CSF2RA (1,347,701), ASMTL (1,482,032), DHRSXY (2,147,553), CD99 (2,619,553), ARSD (2,848,421), ARSE (2,832,011) (Human reference sequence NCBI Build 36.1). PAR1, pseudoautosomal region 1; PAR2, pseudoautosomal region 2. PAR regions are highlighted in orange.
###end p 11
###begin p 12
###xml 253 255 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 256 258 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 274 279 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATRX </italic>
###xml 423 425 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 495 504 491 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 505 507 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 650 658 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 831 833 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 846 851 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATRX </italic>
###xml 1042 1044 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 808 813 <span type="species:ncbi:10090">mouse</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
###xml 864 870 <span type="species:ncbi:9606">humans</span>
The alpha thalassemia mental retardation, X linked (ATRX) protein, transcribed from Xq13.3 belongs to the Sucrose non-fermenting 2 (Snf2) family of enzymes that use the energy of adenosine tri-phosphate (ATP) hydrolysis to disrupt nucleosome stability [13,14]. Mutations in ATRX result in moderate to profound cognitive deficits, facial dysmorphisms, as well as skeletal and urogenital abnormalities, among other symptoms [15]. The chromatin remodeling properties of ATRX have been demonstrated in vitro [16]. In addition to a conserved ATPase/helicase domain, ATRX has an N-terminal zinc finger ATRX-DNMT3A/B-DNMT3L (ADD) domain that is shared with de novo methyltransferases. Several lines of evidence have also linked ATRX to highly repetitive genomic regions including pericentromeric heterochromatin in mouse and human cells [17]. Moreover, ATRX mutations in humans result in aberrant DNA methylation patterns at several repetitive elements, including ribosomal DNA (rDNA) repeats, subtelomeric repeats and Y-specific satellite repeats [18]. These repetitive sequences usually form heterochromatic structures and seem to be specifically targeted by the ATRX protein.
###end p 12
###begin p 13
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
To assess the role of ATRX in brain development, we previously used Cre-loxP recombination to remove Atrx specifically in the forebrain beginning at E8.5. Loss of ATRX in the embryonic forebrain caused hypocellularity and a reduction in forebrain size and loss of the dentate gyrus [19].
###end p 13
###begin p 14
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl</italic>
###xml 93 99 <span type="species:ncbi:9606">humans</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
Genes that are directly regulated by the ATRX protein have not yet been identified in either humans or mice. To identify potential genes that are controlled by ATRX, we performed a screen of gene expression and found that a subset of ancestral PAR1 genes is consistently downregulated in the absence of ATRX in the developing mouse brain. Among them are two potentially novel mouse orthologs of Arse and Asmtl. The only common link between ancestral PAR genes is their adjacent location and shared chromatin environment in the ancestral PAR region. We propose that conserved sequences and/or chromatin features targeted by ATRX were maintained upon translocation of these genes from the PAR1 on the ancestral X chromosome to their current location on mouse autosomes, and allow ATRX to modulate their expression.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Effects of ATRX deletion on forebrain gene expression
###end title 16
###begin p 17
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxg1Cre </italic>
###xml 217 226 217 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Foxg1Cre </italic></sup>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP </italic>
###xml 333 338 333 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>loxP </italic></sup>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxg1</italic>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 565 574 565 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxg1Cre </italic>
###xml 565 574 565 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Foxg1Cre </italic></sup>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1119 1124 1119 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1A, B</xref>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 664 669 <span type="species:ncbi:10090">mouse</span>
The ability of ATRX to remodel chromatin [16] suggests that ATRX can regulate gene expression. To identify possible gene targets of the ATRX protein in the developing mouse brain, we used the previously described AtrxFoxg1Cre mice that lack ATRX in the forebrain [19]. In this model system, Atrx deletion is achieved by crossing AtrxloxP "floxed" mice to mice that express cyclization recombinase (Cre) under the control of the forebrain-specific forkhead box G1 (Foxg1) promoter [20]. We performed microarray analysis to compare the expression profiles of the AtrxFoxg1Cre and control telencephalon at embryonic day 13.5 (E13.5) (n = 3 pairs) using an Affymetrix mouse genome expression array representing approximately 39,000 transcripts [21]. Only probe sets showing a significant difference (p < 0.05) were included in all subsequent studies. By setting a threshold of 1.5 fold change we identified 202 disregulated probesets, and at a threshold of 2 fold change we identified only 22 altered probe sets. Approximately two-thirds of the probe sets demonstrating altered expression were upregulated (Additional file 1A, B).
###end p 17
###begin p 18
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1A</xref>
We next compared gene expression patterns in control and Atrx-null forebrain tissue at postnatal day 0.5 (P0.5) (n = 4 pairs). At a threshold of 1.5 fold change, we identified 304 probe sets and at a threshold of 2 fold change, we identified 57 probe sets showing altered transcript levels. When we compared the microarray results at E13.5 and P0.5 we identified 14 common probe sets that were upregulated and 13 that were downregulated more than 1.5 fold, and one increased and three decreased more than 2 fold (Additional file 1A).
###end p 18
###begin p 19
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
We used GeneSpring to identify significantly overrepresented Gene Ontology (GO) categories in the Atrx-null mouse forebrain. Several statistically and biologically significant categories of upregulated genes were related to the immune response. This could be an indirect response to the increased apoptosis that characterizes the Atrx-null forebrain at E13.5 in the developing cortex and to a lesser extent at P0.5 in the hippocampus [19]. In particular, categories and genes involved in phagocytotic clearing of apoptotic cells, such as complement activation [22], were enriched at both E13.5 and P0.5. Several genes involved in cell adhesion processes were upregulated at P0.5 and, consistent with the abnormal forebrain development described in the Atrx-null forebrain[19], genes involved in neurogenesis and nervous system development were downregulated at both timepoints (Additional file 2).
###end p 19
###begin title 20
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Ancestral pseudoautosomal genes are downregulated in the Atrx-null mouse forebrain
###end title 20
###begin p 21
###xml 510 530 510 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus Dhrsxy </italic>
###xml 765 772 765 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy </italic>
###xml 824 830 824 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 937 960 937 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus Arse </italic>
###xml 1047 1053 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
###xml 1143 1148 1143 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl</italic>
###xml 1291 1297 1291 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy</italic>
###xml 1299 1304 1299 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 1308 1314 1308 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
###xml 1502 1506 1502 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd99</italic>
###xml 1508 1514 1508 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 1518 1524 1518 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Csf2ra</italic>
###xml 2207 2208 2207 2208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 2265 2270 2265 2270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 2274 2279 2274 2279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl</italic>
###xml 2559 2564 2559 2564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 2568 2574 2568 2574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 2641 2642 2641 2642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 2660 2662 2660 2662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1B</xref>
###xml 510 522 <span type="species:ncbi:10090">Mus musculus</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 759 764 <span type="species:ncbi:10090">mouse</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 937 954 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 1056 1059 <span type="species:ncbi:9913">cow</span>
###xml 1114 1117 <span type="species:ncbi:9615">dog</span>
###xml 1119 1124 <span type="species:ncbi:9606">human</span>
###xml 1139 1142 <span type="species:ncbi:10116">rat</span>
###xml 2026 2031 <span type="species:ncbi:10090">mouse</span>
###xml 2105 2110 <span type="species:ncbi:10090">mouse</span>
###xml 2313 2318 <span type="species:ncbi:10090">mouse</span>
Five of the most downregulated transcripts identified in the microarray analysis were unidentified cDNA clones (Affymetrix IDs 1436320_at, 1448057_at, 1443755_at, 1429730_at and 1453066_at; Accessions [GenBank:], [GenBank:], [GenBank:], [GenBank:] and [GenBank:] respectively). To further investigate these probe sets, their NCBI nucleotide sequences were used for a Basic Local Alignment Search Tool nucleotide (BLASTn) search of the nr database. The expressed sequence tag (EST) [GenBank:] has similarity to Mus musculus Dhrsxy ([GenBank:], score = 120, E value 5e-24). The EST [GenBank:] displayed similarity to several unidentified mouse cDNA clones. Interestingly, a BLAST-like Alignment Tool (BLAT) search of this clone showed similarity to intron 1 of mouse Dhrsxy and it could represent an unknown splice variant of Dhrsxy. The EST [GenBank:] is annotated as similar to human Arse and a BLASTn search revealed high similarity to Rattus norvegicus Arse ([GenBank:], score 197, E value 6e-28). BLASTn of [GenBank:] showed high similarity to Asmtl in cow ([GenBank:], score = 248, E value = 6e-62) as well as dog, human, the putative rat Asmtl, and numerous other species. The EST [GenBank:] displayed no significant hits to any sequences by either BLASTn or BLAT. Interestingly, while Dhrsxy, Arse and Asmtl do not display an obvious connection, they do share a common link in that they are all pseudoautosomal genes in eutherians. In addition, the microarray data showed decreased expression of Cd99, Shox2 and Csf2ra, that also lie within the pseudoautosomal region in most eutherians. Therefore, while GO analysis identified a subset of downregulated genes involved in brain development at both timepoints, a more in depth analysis of downregulated targets revealed that many are orthologs of PAR1 genes residing on the tip of the X and Y chromosomes in most placental mammals. Overall, our transcriptional screen identified six of these genes, constituting approximately half of all PAR1 orthologs discovered in the mouse genome so far. The more intriguing aspect of this finding is that in the mouse, these genes no longer reside within the PAR1 region but have translocated to autosomes (Figure 1). It also identified two potential novel PAR1 orthologs-Arse and Asmtl-not previously identified in the mouse genome. At E13.5, these genes represent 6 of the 15 most downregulated transcripts identified by microarray analysis. Strikingly, they constitute 4 of the top 5 most downregulated genes in the microarray performed on P0.5 forebrain tissue (Arse and Shox2 were not significantly decreased in the microarray at P0.5) (Table 1, Additional file 1B). These results suggest that ATRX normally participates in the transcriptional activation of these genes during both the proliferative (E13.5) and more differentiative (P0.5) stages of forebrain development.
###end p 21
###begin p 22
Downregulated genes in the ATRX-null forebrain at E13.5 and P0.5.
###end p 22
###begin p 23
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
1By BLASTn
###end p 23
###begin p 24
###xml 156 161 <span type="species:ncbi:10090">Mouse</span>
cRNA was generated from total forebrain RNA from three pairs of littermate-matched ATRX-null and wild type forebrain tissue and hybridized to an Affymetrix Mouse Genome 430 2.0 Array. Data was analyzed using GeneSpring. Probesets were filtered by fold change (1.8 fold at P0.5, 2 fold at E13.5) and confidence, P < 0.05, and duplicate genes were removed. Ancestral PAR genes are highlighted in grey.
###end p 24
###begin title 25
Verification of gene expression changes
###end title 25
###begin p 26
###xml 142 154 142 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy, Cd99</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Csf2ra</italic>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 924 928 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1080 1086 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
To validate the microarray results, we performed real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of Dhrsxy, Cd99, Csf2ra, Shox2 and also the putative new orthologs of Asmtl and Arse in Atrx-null and control E13.5 and P0.5 forebrain (n = 3 at each time point). Since Arse and Asmtl have not yet been identified in the mouse, we sequenced the PCR products to ensure they corresponded to the transcripts identified on the microarray, and not to other contaminating sequences. The qRT-PCR results confirmed that five of the six genes exhibit decreased expression in the Atrx-null forebrain at E13.5, and that these genes remain downregulated at P0.5 (Figure 2A). In addition, analysis at P17 demonstrated decreased expression of ancestral PAR genes at this later time point as well (Figure 2A). One exception was Shox2 which exhibited highly variable expression differences between the Atrx-null and control tissue at E13.5, P0.5 and P17, ranging from a 170 fold decrease to a 90 fold increase (Figure 2B). Therefore, while the expression of Shox2 is clearly affected by the loss of ATRX protein, the outcome on expression levels appears to be highly variable and does not validate the consistent downregulation observed by microarray analysis.
###end p 26
###begin p 27
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative expression of ancestral PAR genes in ATRX-null mouse forebrains</bold>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 464 470 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
Relative expression of ancestral PAR genes in ATRX-null mouse forebrains. (A) Real-time quantitative RT-PCR of the indicated PAR1 genes showed a decrease in expression in the Atrx-null mouse forebrain. RNA was isolated from littermate-matched Atrx-null and control embryos/mice at E13.5, P0.5 and P17. Results were normalized to beta-actin expression levels. Error bars represent standard error of the mean between biological replicates (n = 3). (B) Expression of Shox2 in seven (E13.5) or three (P0.5 and P17) littermate-matched pairs. Error bars represent standard error of the mean for technical replicates. In (A) and (B) expression levels for the control forebrains were set to one for each reaction (represented by the black bars).
###end p 27
###begin p 28
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
Our discovery that the expression of several ancestral PAR1 genes is controlled by ATRX throughout the early developmental period of the mouse brain reveals an unexpected association between the levels of ATRX protein and the expression of these ancestral PAR1 genes.
###end p 28
###begin title 29
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARS </italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Identification of a novel ARS family mouse homolog
###end title 29
###begin p 30
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARS </italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans, a cluster of ARS genes are located approximately 115 kilobases centromeric to the PAR1 region on the X chromosome, but still possess the ability to escape XCI in females [23]. Located outside the PAR1, these genes do not have an identical homolog on the Y chromosome but have pseudogenes, and in the evolutionary past it is believed that they were true pseudoautosomal genes with identical copies on both the X and Y chromosome [24].
###end p 30
###begin p 31
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
###xml 287 290 <span type="species:ncbi:10116">rat</span>
###xml 312 317 <span type="species:ncbi:9606">human</span>
A multiple alignment of amino acid sequences of [GenBank:] suggested that it is a fragment of the full length ARSE protein, aligning in the middle of the approximately 600 amino acid ARSE protein of multiple other species (Additional file 3). The putative mouse ARSE is 65% identical to rat and 47% identical to human.
###end p 31
###begin p 32
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e</italic>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 102 105 <span type="species:ncbi:10116">rat</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
###xml 563 566 <span type="species:ncbi:10116">rat</span>
Phylogenetic analysis demonstrated that the mouse ARSE sequence clusters with near certainty with the rat ARSE, however, this putative ARSE clustered within the ARSD proteins, not ARSE as expected (Figure 3). Therefore, we propose that we have identified a member of the PAR1 ARS family but at this time cannot determine the exact identity and will refer to this sequence as Arsd/e. We note that the long branch-length between the rodent ARS sequences and the remaining ARSD clade may be an artifact due to the short mouse sequence and its high similarity to the rat sequence, which has undergone seemingly accelerated evolutionary change.
###end p 32
###begin p 33
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phylogenetic tree of ARS proteins</bold>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 35 40 <span type="species:ncbi:9606">Human</span>
###xml 274 277 <span type="species:ncbi:10116">rat</span>
Phylogenetic tree of ARS proteins. Human ARSE [GenGank:] was used as a seed to search the GenBank NR database for orthologs and an approximate maximum-likelihood tree was generated. The putative ARS family gene downregulated in the Atrx-null forebrain clusters closely with rat ARSE but with the ARSD proteins. Entries are annotated with species, chromosome (where known) and GenBank Accession number.
###end p 33
###begin p 34
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ars </italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse</italic>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ars </italic>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 110 113 <span type="species:ncbi:10116">rat</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
###xml 544 549 <span type="species:ncbi:10090">mouse</span>
Comparisons to available mouse Ars gene family members shows that [GenBank:] is more similar to Arse genes in rat than to other mouse arylsulfatase family members (Additional file 4), suggesting that we have identified Arse. This data, combined with our ability to specifically amplify this transcript from mouse brain cDNA and also from a commercially available E15 cDNA library (data not shown), indicates that we have likely identified the mouse homologue of a previously unidentified mouse Ars gene rather then a gene fragment from a known mouse family member.
###end p 34
###begin p 35
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 954 960 954 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e</italic>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 1040 1047 1040 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1140 1147 1140 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 1298 1306 1298 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1348 1357 1348 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1134 1139 <span type="species:ncbi:10090">mouse</span>
To further confirm the identity of [GenBank:], we assessed the outcome of ATRX depletion on Arsd/e expression by RNA interference in the Neuro-2a cultured neuroblastoma cell line. Small interfering RNAs (siRNAs) were used to transiently deplete ATRX, as was done previously [25]. Cells transfected with a non-specific siRNA or no siRNA ("Mock") were used as controls. At 72 hours following siRNA transfection, we monitored the effectiveness of ATRX depletion by indirect immunofluorescence using an ATRX-specific antibody (H300) and qRT-PCR analysis of Atrx expression levels using primers that simultaneously amplify both the full length isoform and the reported truncated isoform [26]. In the siATRX-treated samples, approximately 95% of cells were negative for ATRX (Figure 4A) and Atrx transcript levels were depleted by approximately 5 fold (Figure 4B). We then used qRT-PCR to determine the outcome of ATRX silencing on the expression level of the Arsd/e. Similar to the results obtained in the Atrx-null forebrain, the expression of Arsd/e was decreased two fold (Figure 4B). These findings support that we have identified the mouse Arsd/e and confirm the regulation of this ancestral PAR gene by ATRX, and that this outcome on gene expression can be recapitulated in two different systems: in vivo in the ATRX-null developing forebrain and in vitro in ATRX-depleted cultured neuronal cells.
###end p 35
###begin p 36
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Arsd/e </italic>transcriptional downregulation is recapitulated in ATRX-depleted cells</bold>
###xml 561 566 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 570 577 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 313 319 <span type="species:ncbi:9986">rabbit</span>
Arsd/e transcriptional downregulation is recapitulated in ATRX-depleted cells. (A) RNA interference was used to deplete ATRX in Neuro-2a neuroblastoma cells. Cells were transfected with 8 nM siRNA, fixed after 72 h and processed for immunofluorescence staining using an anti-ATRX primary antibody (H300) and anti-rabbit Alexa 488 secondary antibody, then counterstained with DAPI to detect nuclei. In the siATRX treated samples, approximately 95% of cells were negative for ATRX. Scale bar = 20 muM. (B) Total RNA was isolated for quantitative real-time PCR of Atrx and Arsd/e gene expression at 72 hours post-transfection. Mock (transfection reagent only) expression levels were set to one and a non-specific siRNA was used as a control. Results were normalized to beta-actin expression levels. Error bars represent standard error of the mean (n = 3).
###end p 36
###begin title 37
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL</italic>
Identification of an ASMTL-like gene
###end title 37
###begin p 38
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL </italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMT</italic>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maf </italic>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 372 377 <span type="species:ncbi:9606">Human</span>
###xml 610 613 <span type="species:ncbi:10116">rat</span>
###xml 690 695 <span type="species:ncbi:10090">mouse</span>
###xml 722 725 <span type="species:ncbi:10116">rat</span>
###xml 752 757 <span type="species:ncbi:9606">human</span>
[GenBank:] is the RIKEN cDNA 1810009N02 gene and contains a musculoaponeurotic fibrosarcoma (MAF) domain. A multiple sequence alignment of amino acid sequences was used to further determine the identity of [GenBank:] (Additional file 5). [GenBank:] aligns to the N terminus of ASMTL from multiple other species. The N terminal portion of ASMTL also contains a MAF domain. Human ASMTL was generated by a fusion of a duplicated acetylserotonin O-methyltransferase (ASMT) with the bacterial maf gene [27]. While [GenBank:] contains a MAF domain, it lacks the ASMT domain. However, this is similar to the putative rat ASMTL (Accession [GenBank:]) which also lacks the ASMT domain. The putative mouse ASMTL is 54% identical to rat, and 51% identical to the human protein.
###end p 38
###begin p 39
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 633 638 <span type="species:ncbi:10090">mouse</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 939 944 <span type="species:ncbi:10090">mouse</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
In contrast to ARSE, ASMTL has fewer discernable high-similarity full-length orthologs, and its evolution appears tied to the pseudoautosomal region [27]. Therefore fewer sequences were available for analysis. Figure 5 shows the inferred phylogeny of the ASMTL family, with the primate branches collapsed for clarity. With fairly high bootstrap support, the tree mirrors the known branching of the placental mammals, marsupials, monotremes, birds, amphibians, and fish. The mouse sequence displays the only anomalous placement in the tree, clustering well outside the mammalian clade. Both the placement and the branch-length of the mouse sequence indicate that it is of considerably evolutionarily derived character compared to the putative ancestor, and it appears to have followed an evolutionary path quite different from its paralogs. The lack of the ASMT domain in the mouse sequence may also be responsible for the placement of the mouse sequence in the tree. As with ARSE, some of this divergence may be due to the availability of a partial mouse sequence, but the sequence remains quite unique, nonetheless.
###end p 39
###begin p 40
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phylogenetic tree of ASMTL proteins</bold>
###xml 37 42 <span type="species:ncbi:9606">Human</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
Phylogenetic tree of ASMTL proteins. Human ASMTL [GenBank:] was used as a seed to search the GenBank NR database for orthologs and an approximate maximum-likelihood tree was generated. The putative mouse ASMTL lacks the ASMT domain and clusters well outside the mammalian clade, indicating that it has considerably diverged compared to the putative ancestor. Entries are annotated with species, chromosome (where known) and GenBank Accession number.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATRX </italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1451 1456 1447 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATRX </italic>
###xml 1467 1469 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1526 1528 1518 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 959 964 <span type="species:ncbi:10090">mouse</span>
###xml 1417 1425 <span type="species:ncbi:9606">patients</span>
Mutations in the ATRX gene result in profound cognitive deficits, facial dysmorphisms, as well as skeletal and urogenital abnormalities [15]. Global deletion of Atrx in mouse embryonic stem cells results in a growth disadvantage [28], and conditional loss of Atrx beginning at the 8-16 cell stage leads to embryonic lethality by E9.5 [28]. To bypass early embryonic lethality, we have previously used a conditional approach to delete Atrx in the mouse forebrain beginning at E8.0. These mice have significantly increased cortical progenitor cell apoptosis, causing a reduction in forebrain size and hypocellularity in the neocortex and hippocampus [19]. ATRX is a chromatin remodeling protein [16] and has been proposed to regulate gene expression by modulating chromatin structure, but gene targets of ATRX have not yet been reported. We used a microarray approach to perform large-scale analysis of gene expression changes in the ATRX-null versus wild type mouse forebrain at E13.5 and P0.5. The fact that relatively few genes display altered expression indicates that ATRX is not a global regulator of gene expression but likely controls specific gene loci. It is not clear at this point if ATRX acts by binding directly to DNA or through other unidentified factors to upregulate the ancestral PAR genes identified in our study. The only target of ATRX identified to date is alpha globin which is downregulated in patients with germline or somatic ATRX mutations [29], including alpha-thalassemia myelodysplastic syndrome [30], although evidence that ATRX directly binds to the alpha globin locus is still lacking.
###end p 42
###begin p 43
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd99</italic>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Csf2ra</italic>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhrsxy </italic>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
Through global transcriptional profiling we have now identified a distinct group of genes, the ancestral PAR genes, that are controlled by ATRX in the mouse brain. The human PAR1 contains 24 genes, but only 10 of these have been reported in the mouse genome. Arsd/e, Asmtl, Cd99, Csf2ra, Dhrsxy and Shox2 were among the most downregulated genes identified in the ATRX-null embryonic forebrain. Although these genes are unrelated in function, they share a common ancestral location in the PAR1 of the X chromosome millions of years ago. Our findings demonstrate that they have maintained a mechanism of co-regulation that was conserved in evolution and that requires ATRX, even after their dispersal to autosomes in the mouse genome.
###end p 43
###begin p 44
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD </italic>
###xml 527 533 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL </italic>
###xml 632 639 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHRSXY </italic>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD99 </italic>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 734 741 734 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CSF2RA </italic>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:10090">mouse</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
###xml 677 683 <span type="species:ncbi:9606">humans</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
The PAR1 region exhibits recombination rates approximately 10 times higher than the rest of the human genome [8]. Consequently, genes in this region undergo rapid evolution leading to high interspecies divergence [9,31] making positive identification of homologs difficult. Using multiple sequence alignments and phylogenetic analysis we have identified Arsd/e and Asmtl as putative novel mouse ancestral PAR transcripts. Identity between mouse and human sequences are 47%, 40% and 51% for ARSE [GenBank:], ARSD [GenBank:] and ASMTL [GenBank:], respectively, which is similar to what was reported for other PAR1 genes. For example, DHRSXY exhibits 59% protein identity between humans and mice [9], CD99 46% identity [32], and 35% for CSF2RA [33].
###end p 44
###begin p 45
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD </italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD </italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE </italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSD </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 425 431 <span type="species:ncbi:9606">humans</span>
ARSD and ARSE are members of the arylsulfatase gene family and are located just outside the human PAR1 in a cluster of four arylsulfatase genes [24]. ARSE gene mutations cause X-linked chondrodysplasia punctata, a disorder characterized by abnormalities in cartilage and bone development [34]. ARSE may therefore play a role in the skeletal defects seen in patients with the ATR-X syndrome if it is also regulated by ATRX in humans. The role of ARSD is unknown and it has no demonstrated sulfatase activity despite its high conservation of the N-terminal domain important for catalytic sulfatase activity [35]. ARSE exhibits a restricted pattern of expression [23] while ARSD is ubiquitously expressed [36].
###end p 45
###begin p 46
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL </italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmt </italic>
###xml 140 149 140 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orfE/maf </italic>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMT </italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ASMTL </italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
The function of human ASMTL is unknown. The gene was generated by the duplication of the PAR1 gene Asmt which then fused with the bacterial orfE/maf gene [27]. While other ASMT genes involved in the serotonin/N-acetylserotonin/melatonin pathway are expressed specifically in the human brain, pineal gland and retina [37], ASMTL has a wider expression pattern and may not be involved in this pathway but could still have methyltransferase activity since it retains the necessary domain [27].
###end p 46
###begin p 47
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shox2 </italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX2 </italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 711 717 711 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX2 </italic>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 765 769 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARSE</italic>
###xml 775 780 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHOX </italic>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 179 184 <span type="species:ncbi:10090">mouse</span>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 857 865 <span type="species:ncbi:9606">patients</span>
###xml 943 949 <span type="species:ncbi:9606">humans</span>
We have also identified the mouse Shox2 gene as a potential target of ATRX, and we observed that Shox2 expression levels are highly sensitive to ATRX deficiency in the developing mouse brain. Two SHOX genes, SHOX and SHOX2 have been identified in the human genome, on chromosomes X and 3, respectively. Only one mouse homolog has been identified and is mapped to chromosome 3. Like ARSE, SHOX genes are involved in skeletal development: mutations and deletions in SHOX lead to Leri-Weill dyschondrosteosis [38,39] and non-syndromic idiopathic short stature [40,41], and deletions cause the short stature phenotype seen in Turner syndrome [41,42]. SHOX2 is involved in craniofacial and limb development [43] and SHOX2 mutations lead to cleft palate [44]. Along with ARSE, the SHOX genes provide an intriguing correlation with the skeletal phenotype of ATR-X patients, and future work should address whether these genes are regulated by ATRX in humans.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1211 1213 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
Collectively, our findings suggest that even though they are now located on different chromosomes, a large subset of ancestral PAR genes might share a common sequence or factor that was conserved upon translocation from the pseudoautosomal region on the X chromosome to their current autosomal locations in the mouse genome (Figure 6). Uniform regulation of gene expression may be due to similar regulatory features such as common sequences or epigenetic modifications (e.g. CpG islands). Despite the sequencing of the human X chromosome, gaps remain, most notably in the PAR1 region [45]. The repetitive nature of the PARs likely explains the paucity of sequence data for these regions, and the lack of genomic sequence data for the PAR1 genes that have translocated to autosomes in the mouse. However, we speculate that ATRX could be targeted to repetitive sequences surrounding these genes. One indication that ATRX would preferentially target repetitive sequences comes from studies done in human ATR-X syndrome patients. The analysis of blood samples revealed altered DNA methylation of several highly repeated sequences including ribosomal DNA arrays, the Y-specific repeat DYZ2 and subtelomeric repeats [18]. Conservation of repetitive elements in the PAR1 region of eutherians may have been maintained with the PAR1 genes as they moved to autosomes, and perhaps allow ATRX to target these genes in their modern chromosomal locations.
###end p 49
###begin p 50
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Proposed model for the co-regulation of ancestral PAR genes by ATRX</bold>
###xml 69 73 <span type="species:ncbi:10090">Mice</span>
###xml 78 84 <span type="species:ncbi:9606">humans</span>
###xml 156 162 <span type="species:ncbi:9606">humans</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10116">rats</span>
###xml 680 685 <span type="species:ncbi:10090">mouse</span>
Proposed model for the co-regulation of ancestral PAR genes by ATRX. Mice and humans diverged from a common ancestor approximately 50 million years ago. In humans, genes have remained in the PAR region (orange) while in mice and rats they have translocated to autosomes (grey). Our data suggest that despite the translocation of these genes to autosomes (numbered), they still share a common sequence or chromatin environment that allows ATRX (green circles) to keep these genes active. We propose that this common feature was conserved upon translocation from the pseudoautosomal region on the X and Y chromosomes in the ancestral PAR to their current autosomal locations in the mouse genome. mya, millions of years ago.
###end p 50
###begin p 51
Future work should focus on identifying the molecular mechanisms by which ATRX can co-regulate this diverse set of genes linked by their ancestral localization in the PAR1 region. This will lead to a better understanding of ATRX function in the regulation of chromatin structure and its effects on gene expression in general.
###end p 51
###begin title 52
Methods
###end title 52
###begin title 53
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse husbandry
###end title 53
###begin p 54
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP </italic>
###xml 86 91 86 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>loxP </italic></sup>
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxg1Cre </italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>r</italic></sup>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Mice conditionally deficient for ATRX in the forebrain were generated by crossing AtrxloxP females with heterozygous Foxg1Cre male mice, as previously described [19]. Pregnant females were sacrificed at E13.5, embryos were recovered and yolk sac DNA was genotyped by PCR using the primers 17F, 18R and neoras described previously [19]. For newborns (P0.5) and juveniles (P17), pups were sacrificed and tail DNA was used for genotyping as previously described [19].
###end p 54
###begin title 55
Microarray analysis
###end title 55
###begin p 56
###xml 843 846 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">th </italic>
###xml 843 846 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>th </italic></sup>
###xml 915 920 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx </italic>
###xml 1048 1052 1045 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 218 223 <span type="species:ncbi:10090">Mouse</span>
Total forebrain RNA (10 mug) was isolated from three E13.5 and four P0.5 pairs of littermate-matched ATRX-null and control embryos using the RNeasy Mini kit (Qiagen). cRNA was generated and hybridized to an Affymetrix Mouse Genome 430 2.0 Array at the London Regional genomics Center (London, Canada). For the analysis at E13.5, RNA from two forebrains was pooled for each array. Probe signal intensities were generated using GCOS1.4 (Affymetrix Inc., Santa Clara, CA) using default values for the Statistical Expression algorithm parameters and a Target Signal of 150 for all probe sets and a Normalization Value of 1. Gene level data was generated using the RMA preprocessor in GeneSpring GX 7.3.1 (Agilent Technologies Inc., Palo Alto, CA). Data were then transformed (measurements less than 0.01 set to 0.01), normalized per chip to the 50th percentile, and per gene to control samples. Probe sets representing Atrx transcripts were removed (10 sets). Remaining probe sets were filtered by fold change of either >/=1.5 or 2 between control and Atrx-null samples, and by confidence level of P < 0.05. Heatmaps were generated using the GeneSpring hierarchical clustering gene tree function. Significantly overrepresented GO categories were determined using GeneSpring: at E13.5 and P0.5, probe sets were filtered by 1.5 fold change, P < 0.05 and categorized as either up or downregulated. Where there were multiple probe sets for a gene, duplicates were removed. P < 0.001 was used as the significance cutoff.
###end p 56
###begin title 57
qRT-PCR
###end title 57
###begin p 58
###xml 647 648 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 984 996 951 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink">(-1/slope)-1</sup>
###xml 1041 1043 1008 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Total RNA was isolated using the RNeasy Mini kit (QIAGEN). First-strand cDNA was synthesized from 3 mug of total RNA using the SuperScripttrade mark II Reverse Transcriptase kit (Invitrogen) with 25 mM dNTPs (GE Healthcare), 1 muL porcine RNAguard (GE Healthcare) and 3 muL random primers (GE Healthcare). PCR reactions were performed on a Chromo4 Continuous Fluorescence Detector in the presence of iQtrade mark SYBR Green Supermix and recorded using the Opticon Monitor 3 software (Bio-Rad Laboratories, Inc.). Samples were amplified as follows: 95degreesC for 10 seconds, annealed for 20 seconds, 72degreesC for 30 seconds (See Additional file 6 for primer sequences and annealing temperatures). After amplification a melting curve was generated, and samples were run on a 1.5% agarose gel (75 V for 1 h) to visualize amplicon purity. Standard curves were generated for each primer pair using three fold serial dilutions of control cDNA. Primer efficiency was calculated as E = [10(-1/slope)-1]*100, where a desirable slope is -3.32 and r2 > 0.99. Samples were normalized to beta-actin expression and relative gene expression levels were calculated using GeneX software (Bio-Rad Laboratories, Inc.).
###end p 58
###begin p 59
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl</italic>
For Arsd/e and Asmtl, the PCR products were gel extracted using the QIAquick Gel Extraction Kit (QIAGEN) according to the manufacturer's instructions and sequenced at the DNA Sequencing Facility at Robarts Research Institute (London, Canada).
###end p 59
###begin title 60
Bioinformatics analysis of novel ancestral PAR genes
###end title 60
###begin p 61
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Probeset sequences were obtained from the Netaffx website  and used for BLASTn searches . For calculation of interspecies similarity, sequences were obtained from NCBI RefSeq  or Ensemble  where RefSeq sequences were not available, and pairwise comparisons made using Jalview [46].
###end p 61
###begin p 62
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 473 479 <span type="species:ncbi:13443">Coffee</span>
###xml 999 1004 <span type="species:ncbi:10090">mouse</span>
###xml 1131 1136 <span type="species:ncbi:10090">mouse</span>
###xml 1295 1300 <span type="species:ncbi:10090">mouse</span>
###xml 1449 1454 <span type="species:ncbi:10090">mouse</span>
For generation of trees and sequence alignments, human ARSE (SwissProt , RefSeq NP_000038) and human ASMTL (SwissProt , RefSeq NP_004183) were used as seeds and the GenBank NR database was searched for high-similarity, full-length orthologs and paralogs. Fifty-nine ARSE and twenty-two ASMTL sequences met or exceeded the similarity cutoff, with resultant species spanning the metazoa from anemone and urchin to a diverse set of vertebrates. Sequences were aligned using T-Coffee 5.56 [47] using default parameters. Alignments were manually adjusted via inspection prior to further analysis. Approximate maximum-likelihood trees were built using PHYML 2.4.5 [48] using the WAG model of protein evolution [49] and a seven-category Gamma-plus-invariant model of rate heterogeneity. All rate parameters were estimated from the data. One hundred bootstrap replicates were performed to assess support for the inferred tree topology. All trees are presented as midpoint-rooted phylograms. Since the given mouse sequences were quite short compared to the full protein length, two sets of trees were built for each family to assess if the mouse sequences were long enough to definitively support their taxonomic clustering. One set utilized a "trimmed" alignment where all alignment columns outside the mouse sequence domain were removed. The trees produced with this trimmed alignment were compared with the set of trees produced from the alignment of the mouse sequences to their respective full-length proteins. For both ARSD/E and ASMTL, very little difference was observed between full-length and trimmed-alignment trees. The trimmed alignments tended to exaggerate sequence divergence and modestly lower bootstrap support levels. Overall topology did not appear significantly different, however, and the text references the full-length sequence phylogeny exclusively.
###end p 62
###begin title 63
Cell culture and RNA interference
###end title 63
###begin p 64
###xml 50 52 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 147 149 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 543 545 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 88 94 <span type="species:ncbi:9913">bovine</span>
Neuro-2a cells were grown at 37degreesC with 5% CO2 in EMEM supplemented with 10% fetal bovine serum (Sigma-Aldrich). For siRNA treatment, 1.5 x 104 cells were plated in a plastic six well dish (Corning Incorporated) on glass coverslips and allowed to grow to 15% confluency (approximately 24 hours). Cultures were transfected using Lipofectamine 2000 (Invitrogen) with 8 nM siATRX (Dharmacon), a non-specific control siRNA (Sigma-Aldrich), or with no siRNA ("Mock") according to the manufacturers' instructions (for siRNA sequences refer to [25]). Total RNA was extracted from cells after 72 hours, cDNA was generated and qPCR analysis performed as described above. Alternatively, cells were processed for immunofluorescence staining as described below.
###end p 64
###begin title 65
Immunofluorescence
###end title 65
###begin p 66
###xml 179 183 <span type="species:ncbi:9925">goat</span>
###xml 189 195 <span type="species:ncbi:9986">rabbit</span>
Neuro-2a cells were fixed using 3:1 methanol:ethanol, incubated for 1 h with the primary antibody (H300 anti-ATRX, 1:100 dilution; Santa Cruz) followed by the secondary antibody (goat-anti rabbit Alexa 594, 1:1500 dilution; Molecular Probes), then counterstained with 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) for 5 min. Coverslips were mounted with Vectashield (Vector Laboratories), Z-stack images were captured using a Leica DMI6000b inverted microscope and Openlab software (v5.0, Improvision) and processed using Volocity software (v4.0, Improvision); deconvolution was performed using iterative restoration set with a confidence limit of 95%.
###end p 66
###begin title 67
Abbreviations
###end title 67
###begin p 68
PAR: Pseudoautosomal region; SWI/SNF: Switching/Sucrose non-fermenting; ATRX: alpha thalassemia mental retardation: X linked; XCI: X chromosome inactivation; Csf2ra: Colony stimulating factor 2 receptor: alpha; Cd99: CD99 antigen; Dhrsxy: dehydrogenase/reductase (SDR family) X chromosome; Ars: Arylsulfatase; Asmtl: acetylserotonin O-methyltransferase-like; ADD: Atrx Dnmt3a/b Dnmt3L; rDNA: ribosomal DNA; Foxg1: forkhead box G1; Cre: cyclization recombinase; EST: Expressed Sequence Tag; BLASTn: Basic Local Alignment Search Tool nucleotide; BLAT: BLAST-like Alignment Tool; E: embryonic; P: postnatal; Sts: steroid sulfatase; siRNA: Small interfering RNA; RT-PCR: reverse-transcriptase polymerase chain reaction; MAF: musculoaponeurotic fibrosarcoma; ASMT: acetylserotonin O-methyltransferase; SDR: Short-chain dehydrogenase/reductase; SHOX: short stature homeobox; ATR-X: alpha thalassemia mental retardation: X linked (referring to the syndrome); Neuro-2a: Neuroblastoma-2a; DAPI: 4',6-diamidino-2-phenylindole; GO: Gene Ontology.
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asmtl </italic>
ML performed animal husbandry, isolated RNA from E13.5 forebrains for microarray and qRT-PCR analysis, analyzed microarray results, carried out qRT-PCR analysis, cell culture and immunofluorescence, initial bioinformatics analysis and wrote the manuscript. AF performed the phylogenetic analysis of Arsd/e and Asmtl and provided expertise on the bioinformatics analysis. DT performed animal husbandry and extracted RNA from P0.5 forebrains for microarray and qRT-PCR analysis. CS performed animal husbandry and provided technical expertise. NB provided technical expertise, intellectual direction and assisted with the writing of the manuscript.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional file 1
###end title 72
###begin p 73
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of microarray results</bold>
###xml 187 192 <span type="species:ncbi:10090">Mouse</span>
Summary of microarray results. cRNA was generated from total forebrain RNA from three pairs of littermate-matched ATRX-null and wild type forebrain tissue and hybridized to an Affymetrix Mouse Genome 430 2.0 Array. Data was analyzed using GeneSpring. Probe sets were filtered by fold change (1.5 and 2 fold at E13.5 and P0.5) and confidence, P < 0.05, and duplicate genes were removed. (A) Venn diagrams to categorize probe sets according to developmental timepoint and fold change in expression levels. (B) Hierarchical clustering of differentially expressed probe sets. Approximately two-thirds of the misregulated genes are upregulated. Ancestral PAR genes are consistently downregulated at both timepoints and are indicated by blue text. Probe sets were filtered by 1.5 fold or 2 fold change, P < 0.05, at either E13.5 or P0.5. Normalized expression levels are displayed.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 2
###end title 75
###begin p 76
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Significantly misregulated GO categories</bold>
Significantly misregulated GO categories. GeneSpring was used to identify significantly overrepresented GO categories. Probe sets were filtered by 1.5 fold change, P < 0.05 and categorized as either up or downregulated. When there were multiple probe sets for a gene, duplicates were removed. P < 0.001 was used as the significance cutoff.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 3
###end title 78
###begin p 79
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid alignment of a small portion of ARSD/E between multiple species</bold>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 645 652 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsd/e </italic>
###xml 107 113 <span type="species:ncbi:13443">Coffee</span>
###xml 208 213 <span type="species:ncbi:10090">Mouse</span>
###xml 245 248 <span type="species:ncbi:10116">rat</span>
###xml 289 296 <span type="species:ncbi:9031">chicken</span>
###xml 309 312 <span type="species:ncbi:9913">cow</span>
###xml 325 328 <span type="species:ncbi:9615">dog</span>
###xml 341 346 <span type="species:ncbi:9796">horse</span>
###xml 379 384 <span type="species:ncbi:9606">human</span>
###xml 397 405 <span type="species:ncbi:9258">platypus</span>
###xml 461 464 <span type="species:ncbi:10116">rat</span>
###xml 483 486 <span type="species:ncbi:9615">dog</span>
###xml 499 504 <span type="species:ncbi:9796">horse</span>
###xml 517 522 <span type="species:ncbi:9606">human</span>
###xml 576 584 <span type="species:ncbi:9258">platypus</span>
###xml 597 604 <span type="species:ncbi:9031">chicken</span>
###xml 617 626 <span type="species:ncbi:7955">zebrafish</span>
###xml 639 644 <span type="species:ncbi:10090">Mouse</span>
Amino acid alignment of a small portion of ARSD/E between multiple species. Sequences were aligned using T-Coffee 5.56 [47] using default parameters, edited using JalView [46] and shaded using Boxshade [51]. Mouse ARSD/E has highest identity to rat ARSE (65%). Accession numbers are ARSE: chicken [GenBank:], cow [GenBank:], dog [GenBank:], horse [GenBank:], macaque [GenBank:], human [GenBank:], platypus [GenBank:], opossum [GenBank:], pufferfish [GenBank:], rat [GenBank:]. ARSD: dog [GenBank:], horse [GenBank:], human [GenBank:], macaque [GenBank:], opossum, [GenBank:], platypus [GenBank:], chicken [GenBank:], zebrafish [GenBank:]. Mouse Arsd/e translated from [GenBank:].
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 4
###end title 81
###begin p 82
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparisons of Ars family members</bold>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ars </italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsa </italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsb </italic>
###xml 299 308 299 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsc/Sts </italic>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsg </italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsi </italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsj </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arse </italic>
###xml 413 422 413 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arsc/Sts </italic>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 114 117 <span type="species:ncbi:10116">rat</span>
###xml 388 391 <span type="species:ncbi:10116">rat</span>
###xml 409 412 <span type="species:ncbi:10116">rat</span>
Comparisons of Ars family members. The transcript identified as a putative mouse Arse ortholog is more similar to rat Arse then to any other Ars family members. Pairwise percent identities were calculated using Jalview [46]. Accession numbers are: Arse [GenBank:], Arsa [GenBank:], Arsb [GenBank:], Arsc/Sts [GenBank:], Arsg [GenBank:], Arsi [GenBank:], Arsj [GenBank:], Arsk [GenBank:], rat Arse [GenBank:], rat Arsc/Sts [GenBank:].
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 5
###end title 84
###begin p 85
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid alignment of the N terminal of ASMTL between multiple species</bold>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 105 111 <span type="species:ncbi:13443">Coffee</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 294 297 <span type="species:ncbi:10116">rat</span>
###xml 383 388 <span type="species:ncbi:9606">human</span>
###xml 401 410 <span type="species:ncbi:9600|species:ncbi:9601">orangutan</span>
###xml 423 433 <span type="species:ncbi:9598">chimpanzee</span>
###xml 450 453 <span type="species:ncbi:9913">cow</span>
###xml 466 469 <span type="species:ncbi:9615">dog</span>
###xml 499 506 <span type="species:ncbi:9031">chicken</span>
###xml 519 528 <span type="species:ncbi:7955">zebrafish</span>
###xml 541 549 <span type="species:ncbi:9258">platypus</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
Amino acid alignment of the N terminal of ASMTL between multiple species. Sequences were aligned using T-Coffee 5.56 [47] using default parameters, edited using JalView [46] and shaded using Boxshade [51]. The putative mouse ASMTL aligns within the N terminal MAF domain and is most similar to rat ASMTL (54% identity) which also contains only the MAF domain. Accession numbers are: human [GenBank:], orangutan [GenBank:], chimpanzee [XP_001137696], cow [GenBank:], dog [GenBank:], frog [GenBank:], chicken [GenBank:], zebrafish [GenBank:], platypus [GenBank:], mouse [GenBank:].
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Additional file 6
###end title 87
###begin p 88
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Conditions for quantitative real-time PCR</bold>
Conditions for quantitative real-time PCR. Primer sequences and annealing temperatures used for quantitative real-time PCR confirmation of downregulated ancestral PAR genes.
###end p 88
###begin p 89
Click here for file
###end p 89
###begin title 90
Acknowledgements
###end title 90
###begin p 91
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atrx</italic>
###xml 61 66 61 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 41 48 <span type="species:ncbi:9581">Gibbons</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
We thank Douglas R. Higgs and Richard J. Gibbons for the AtrxloxP mice. We wish to gratefully acknowledge SHARCNET [50] for providing computational resources. M.L. and D.T were supported by Curtis Cadman Foundation and Natural Sciences and Engineering Research Council of Canada (NSERC) fellowships, respectively. This work was funded by the Canadian Institutes for Health Research (MOP-74748) and NSERC (313403) operating grants to N.G.B. N.G.B. is the recipient of a CIHR New Investigator award.
###end p 91
###begin article-title 92
The degeneration of Y chromosomes
###end article-title 92
###begin article-title 93
Sex chromosome specialization and degeneration in mammals
###end article-title 93
###begin article-title 94
###xml 59 64 <span type="species:ncbi:9606">human</span>
The origin and evolution of the pseudoautosomal regions of human sex chromosomes
###end article-title 94
###begin article-title 95
X-chromosome inactivation as a system of gene dosage compensation to regulate gene expression
###end article-title 95
###begin article-title 96
X-inactivation profile reveals extensive variability in X-linked gene expression in females
###end article-title 96
###begin article-title 97
###xml 45 49 <span type="species:ncbi:10090">Mice</span>
A Short Pseudoautosomal Region in Laboratory Mice
###end article-title 97
###begin article-title 98
###xml 51 56 <span type="species:ncbi:9606">human</span>
Evidence for heterogeneity in recombination in the human pseudoautosomal region: high resolution analysis by sperm typing and radiation-hybrid mapping
###end article-title 98
###begin article-title 99
###xml 33 38 <span type="species:ncbi:9606">Human</span>
###xml 71 76 <span type="species:ncbi:10090">Mouse</span>
Differential Divergence of Three Human Pseudoautosomal Genes and Their Mouse Homologs: Implications for Sex Chromosome Evolution
###end article-title 99
###begin article-title 100
Long homopurine*homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region
###end article-title 100
###begin article-title 101
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
The human pseudoautosomal GM-CSF receptor alpha subunit gene is autosomal in mouse
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse CD99 participates in T-cell recruitment into inflamed skin
###end article-title 102
###begin article-title 103
Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions
###end article-title 103
###begin article-title 104
ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome
###end article-title 104
###begin article-title 105
Molecular-clinical spectrum of the ATR-X syndrome
###end article-title 105
###begin article-title 106
The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies
###end article-title 106
###begin article-title 107
Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes
###end article-title 107
###begin article-title 108
Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation
###end article-title 108
###begin article-title 109
The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis
###end article-title 109
###begin article-title 110
Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures
###end article-title 110
###begin article-title 111
###xml 8 12 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 12 17 <span type="species:ncbi:10090">Mouse</span>
GeneChip(R) Mouse Genome 430 2.0 Array
###end article-title 111
###begin article-title 112
Role of complement and complement regulators in the removal of apoptotic cells
###end article-title 112
###begin article-title 113
A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy
###end article-title 113
###begin article-title 114
Characterization of a cluster of sulfatase genes on Xp22.3 suggests gene duplications in an ancestral pseudoautosomal region
###end article-title 114
###begin article-title 115
Loss of ATRX leads to chromosome cohesion and congression defects
###end article-title 115
###begin article-title 116
A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain
###end article-title 116
###begin article-title 117
###xml 63 68 <span type="species:ncbi:9606">human</span>
Gene duplications as a recurrent theme in the evolution of the human pseudoautosomal region 1: isolation of the gene ASMTL
###end article-title 117
###begin article-title 118
Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues
###end article-title 118
###begin article-title 119
Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)
###end article-title 119
###begin article-title 120
Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies
###end article-title 120
###begin article-title 121
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Rapid evolution of human pseudoautosomal genes and their mouse homologs
###end article-title 121
###begin article-title 122
Rapid divergency of rodent CD99 orthologs: implications for the evolution of the pseudoautosomal region
###end article-title 122
###begin article-title 123
###xml 28 34 <span type="species:ncbi:10090">murine</span>
Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex
###end article-title 123
###begin article-title 124
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata
###end article-title 124
###begin article-title 125
Arylsulfatase D gene in Xp22.3 encodes two protein isoforms
###end article-title 125
###begin article-title 126
###xml 24 29 <span type="species:ncbi:9606">human</span>
Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells
###end article-title 126
###begin article-title 127
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Circadian regulation of hydroxyindole-O-methyltransferase mRNA levels in rat pineal and retina
###end article-title 127
###begin article-title 128
SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)
###end article-title 128
###begin article-title 129
Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis
###end article-title 129
###begin article-title 130
###xml 105 113 <span type="species:ncbi:9606">children</span>
Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature
###end article-title 130
###begin article-title 131
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
###end article-title 131
###begin article-title 132
The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome
###end article-title 132
###begin article-title 133
SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development
###end article-title 133
###begin article-title 134
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate
###end article-title 134
###begin article-title 135
###xml 24 29 <span type="species:ncbi:9606">human</span>
The DNA sequence of the human X chromosome
###end article-title 135
###begin article-title 136
The Jalview Java alignment editor
###end article-title 136
###begin article-title 137
###xml 2 8 <span type="species:ncbi:13443">Coffee</span>
T-Coffee: A novel method for fast and accurate multiple sequence alignment
###end article-title 137
###begin article-title 138
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood
###end article-title 138
###begin article-title 139
A general empirical model of protein evolution derived from multiple protein families using a maximum-likelihood approach
###end article-title 139
###begin article-title 140
The Canadian Shared Hierarchical Academic Research Computing Network
###end article-title 140
###begin article-title 141
BoxShade Server 3.21
###end article-title 141

